Physician profile
Jeffrey Silver
NPI 1770585978
$38,570.64
in general payments reported to CMS, 2019-2025
39 companies · $566 in 2025
The $566 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,921 · 2020: $519 · 2021: $9,947 · 2022: $10K · 2023: $13K · 2024: $1,418 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $2,620 · Travel and Lodging: $2,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,000.00 |
| Food and Beverage | $2,620.34 |
| Travel and Lodging | $2,208.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $30,352.06 | 2021-2024 | Davinci Xi, Da Vinci Surgical System |
| Abbott Laboratories | $1,410.25 | 2019-2025 | Navitor |
| Edwards Lifesciences Corporation | $1,407.22 | 2019-2024 | Sapien 3 Ultra Resilia |
| Sanofi-Aventis U.S. LLC | $1,208.00 | 2019 | |
| Abiomed | $860.23 | 2021-2025 | Impella |
| Philips North America LLC | $599.68 | 2019 | |
| Medtronic, INC. | $301.62 | 2021-2025 | Penditure, Penditure |
| Atricure, INC. | $300.45 | 2021-2024 | |
| Chiesi USA, INC. | $268.01 | 2022-2025 | Cleviprex, Curosurf, Kengreal |
| Lemaitre Vascular, INC. | $215.21 | 2019-2025 | Restoreflow, Tyke, Patch, Pledget and Intracardiac |
| Livanova USA, INC. | $177.41 | 2022-2023 | Lifesparc, Tandemlife |
| Janssen Pharmaceuticals, INC | $140.07 | 2019-2023 | Xarelto |
| Inari Medical, INC. | $133.64 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $122.89 | 2024-2025 | Keytruda |
| Getinge USA Sales, LLC | $117.18 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Ultima Activator II Drive Mechanism |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.